This Saturday, April 27th, 2019 several Sentry BioPharma Services team members will be proudly participating in the 2019 Komen Central Indiana Race for the Cure ®. Over the years this event has raised more than $2 billion dollars to help fund research, education, screening and treatment. ...
Monday, April 22, 2019 | Read More
In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...
Wednesday, September 12, 2018 | Read More
In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...
Tuesday, September 11, 2018 | Read More
Sentry's Highly Protected Risk (HPR) facility is strategically located in Indianapolis, Indiana, the "Crossroads of America." This location enables Sentry to act as fast, expedient worldwide pharmaceutical distributors, providing a variety of built-in advantages for logistical efficiency.
Sentry's location is adjacent to Indianapolis International Airport, the eighth largest cargo airport in the U.S. The airport, just minutes away, serves 12 major airlines with more than 280 daily flights.
Four major interstates convene in Indianapolis (I-65, I-69, I-70 and I-74), providing one day driving access to 75% of all U.S. businesses.
Proximity to FedEx's 2nd largest hub enables Sentry to capitalize on late drop times, promoting effective west coast (U.S.) and global pharmaceutical distribution.